# NVIDIA Developer Relations & Community Submissions

Ready-to-publish technical write-ups for the **NVIDIA Developer Forum**, LinkedIn, and NVIDIA Developer Champions portfolio.

---

## 1. NVIDIA Developer Forum Submission

**Category:** Healthcare & Life Sciences / BioNeMo  
**Title:** Agentic BioNeMo: An Autonomous Multi-Agent AI Scientist for Target-to-Lead Drug Discovery (NVIDIA NIM MolMIM + DiffDock + 3D Cockpit)  
**Tags:** `BioNeMo`, `NIM`, `MolMIM`, `DiffDock`, `AI-Agents`, `Cheminformatics`, `Drug-Discovery`, `Streamlit`  
**GitHub Link:** https://github.com/Jorwalzzz/bionemo-agentic-scientist  

### Forum Post Body:

Hi NVIDIA Community,

With the rapid emergence of agentic workflows in enterprise AI, we asked: **Can an autonomous multi-agent AI system coordinate NVIDIA NIM microservices to drive end-to-end target-to-lead drug discovery?**

Today, we are open-sourcing **Agentic BioNeMo**—an autonomous multi-agent artificial intelligence discovery system powered by **NVIDIA NIM (MolMIM + DiffDock)**, **RDKit**, and an **interactive 3D Web Cockpit**.

---

### The Architecture: 5 Specialized AI Agents

Rather than a single monolithic script, the system orchestrates 5 specialized agent personas collaborating in a closed loop:

1. **🧬 Target Scout Agent**: Resolves biological target queries (e.g. `KRAS G12D`, `EGFR T790M`, `BRAF V600E`), retrieves 3D crystal structures (`8AZV`, `2ITZ`, `4MNE`), cleans heteroatoms, validates canonical 20 IUPAC residues, and maps active pocket residues.
2. **🧪 Generative Chemist Agent**: Queries **NVIDIA NIM MolMIM** via CMA-ES latent space exploration to synthesize diverse bioisosteric derivatives around the parent scaffold.
3. **🛡️ ADMET & MedChem Critic Agent**: Evaluates molecules against Lipinski Rule of 5, Veber criteria, Quantitative Drug-likeness (QED), PAINS structural alerts, and hERG cardiotoxicity heuristics.
4. **📐 Biophysics & Docking Agent**: Generates 3D conformers and executes reverse diffusion docking via **NVIDIA NIM DiffDock**, calculating binding free energy ($\Delta G$ in kcal/mol) and mapping residue contacts.
5. **👑 Principal Investigator (PI) Agent**: Arbitrates the multi-objective Pareto Frontier ($\Delta G$ vs QED vs SAScore), identifies chemical liabilities, triggers **Round 2 feedback steering directives**, and authors the formal **Candidate Selection Dossier**.

---

### Validation Case Study: Targeting the KRAS G12D Switch-II Pocket

In clinical oncology, **KRAS G12D** is the primary oncogenic driver in ~90% of pancreatic ductal adenocarcinomas and ~40% of colorectal cancers.
- **Reference Scaffold**: MRTX1133
- **Target Pocket**: Switch-II groove (PDB: `8AZV`, residues Asp12, Gly60, Gln61, Tyr96)
- **Top Nominated Lead**: `NIM-LEAD-01-06`
- **Predicted Binding Energy ($\Delta G$):** **-9.05 kcal/mol** (forming direct electrostatic interactions with mutant Asp12 and Tyr96)
- **Drug-Likeness (QED):** Compliant with 0 PAINS alerts
- **Autonomous Feedback**: Round 1 top lead had high molecular weight; the PI agent automatically issued a Round 2 directive to reduce steric bulk and optimize synthetic accessibility.

---

### Interactive 3D Web Cockpit:
We also built a Streamlit + `py3Dmol` interface that lets researchers:
- Watch the multi-agent reasoning stream in real-time.
- Rotate, zoom, and inspect 3D docked poses with electrostatic surfaces right in the browser.
- Inspect the 300 DPI multi-objective Pareto frontier.
- Export candidate SDFs and clinical dossiers with one click.

Repository & Full Documentation:  
👉 https://github.com/Jorwalzzz/bionemo-agentic-scientist

We would love feedback from the NVIDIA BioNeMo engineering and DevRel teams on multi-target selectivity profiling and local NIM container deployment!

---

## 2. LinkedIn Technical Announcement Post

🚀 **Excited to open-source Agentic BioNeMo: An Autonomous Multi-Agent AI Scientist for Target-to-Lead Drug Discovery!**

What happens when you combine autonomous AI agent architecture with NVIDIA BioNeMo & NIM microservices?

You get an automated discovery studio where 5 specialized AI agents collaborate to discover, filter, and optimize drug candidates against high-priority cancer targets like **KRAS G12D** and **EGFR T790M**:

1️⃣ **Target Scout Agent:** Resolves disease targets, extracts 3D crystal structures, and validates canonical sequences.  
2️⃣ **Generative Chemist Agent:** Leverages **NVIDIA NIM MolMIM** for CMA-ES latent exploration around seed scaffolds.  
3️⃣ **ADMET Critic Agent:** Rigorous RDKit filtration across Lipinski rules, QED, PAINS alerts, and SAScore.  
4️⃣ **Biophysics Docking Agent:** Uses **NVIDIA NIM DiffDock** for 3D molecular docking and binding energy calculation.  
5️⃣ **Principal Investigator Agent:** Arbitrates the multi-objective Pareto frontier and steers closed-loop feedback refinement.

🔬 **Case Study Result:** For KRAS G12D (PDB: 8AZV), the pipeline autonomously nominated lead `NIM-LEAD-01-06` with a predicted binding affinity of **-9.05 kcal/mol** contacting key pocket residues Asp12, Gly60, and Tyr96.

Includes a full **Interactive 3D Web Cockpit (Streamlit + py3Dmol)** to inspect docked ligand conformers in real-time!

Code, CI/CD pipeline, and 300 DPI plots are available on GitHub:  
👉 https://github.com/Jorwalzzz/bionemo-agentic-scientist

#NVIDIA #BioNeMo #NIM #AIAgents #GenerativeAI #DrugDiscovery #Cheminformatics #Streamlit #Python
